Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

260 frames-per-second 648x488 resolution division-of-focal-plane polarimeter with structural dynamics and tracking applications.

York T, Marinov R, Gruev V.

Opt Express. 2016 Apr 18;24(8):8243-52. doi: 10.1364/OE.24.008243.

PMID:
27137263
2.

[TREATMENT OF EXTREMELY PREMATURE NEWBORN INFANT WITH INO. CLINICAL CASE].

Radulova P, Slancheva B, Marinov R.

Akush Ginekol (Sofiia). 2015;54(9):52-7. Bulgarian.

PMID:
26863798
3.

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

Low DE, File TM Jr, Eckburg PB, Talbot GH, David Friedland H, Lee J, Llorens L, Critchley IA, Thye DA; FOCUS 2 investigators.

J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii33-44. doi: 10.1093/jac/dkr097.

PMID:
21482568
4.

Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.

Weinstein SF, Corren J, Murphy K, Nolte H, White M; Study Investigators of P04431.

Allergy Asthma Proc. 2010 Jul-Aug;31(4):280-9. doi: 10.2500/aap.2010.31.3381. Epub 2010 Aug 3.

PMID:
20687982
5.

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.

Tanaseanu C, Milutinovic S, Calistru PI, Strausz J, Zolubas M, Chernyak V, Dartois N, Castaing N, Gandjini H, Cooper CA; 313 Study Group.

BMC Pulm Med. 2009 Sep 9;9:44. doi: 10.1186/1471-2466-9-44.

6.

Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.

Dartois N, Castaing N, Gandjini H, Cooper A; Tigecycline 313 Study Group.

J Chemother. 2008 Oct;20 Suppl 1:28-35.

PMID:
19036672
7.

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.

Tanaseanu C, Bergallo C, Teglia O, Jasovich A, Oliva ME, Dukart G, Dartois N, Cooper CA, Gandjini H, Mallick R; 308 Study Group; 313 Study Group.

Diagn Microbiol Infect Dis. 2008 Jul;61(3):329-38. doi: 10.1016/j.diagmicrobio.2008.04.009. Epub 2008 May 27.

PMID:
18508226
8.

First cluster of travel-associated legionnaires' disease detected in Bulgarian citizens.

Tomova I, Marinov R, Maeva I.

Euro Surveill. 2007 Apr 12;12(4):E070412.2. No abstract available.

PMID:
17439804
9.

[Value of the immune response in assessing the efficacy of an antimalarial treatment].

Marinov R, Teodorescu C, Sandu M, Brezuleanu S.

Rev Med Chir Soc Med Nat Iasi. 1987 Apr-Jun;91(2):313-7. Romanian. No abstract available.

PMID:
3317691
10.

The significance of the imported P. vivax in the epidemiological context in Moldavia (Romania).

Marinov R, Teodorescu C, Sandu M, Brezuleanu S.

Rev Med Chir Soc Med Nat Iasi. 1986 Jan-Mar;90(1):73-6. No abstract available.

PMID:
3532263
11.

[Usefulness of the P. berghei antigen compared with those of P. vivax and P. malariae in evaluating the immune response in human malaria].

Marinov R.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1985 Apr-Jun;30(2):149-54. Romanian. No abstract available.

PMID:
3903951
12.

[Important epidemiological characteristics of cases of imported malaria].

Marinov R, Teodorescu C, Sandu M, Brebenel G, Trifan G, Susanu E, Stanciu C, Stratulat C.

Rev Med Chir Soc Med Nat Iasi. 1984 Jul-Sep;88(3):515-7. Romanian. No abstract available.

PMID:
6400141
13.

[Use of the circumlarval precipitation test for the diagnosis and epidemiological survey of trichinosis].

Marinov R, Brezuleanu S, Sandu M, Popa I, Brebenel G, Stratulat C.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1984 Jan-Mar;29(1):47-9. Romanian. No abstract available.

PMID:
6729349
14.

[The importance of some factors which endanger the eradication of malaria in Moldavia].

Marinov R, Teodorescu C.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1980 Apr-Jun;25(2):121-8. Romanian.

PMID:
7423089
15.

[Effectiveness of radical treatment in infections with antochthonous strains of P. malariae].

Marinov R, Dranga A, Mircea M.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1979 Oct-Dec;24(4):235-8. Romanian.

PMID:
531444
16.

[Prospective evaluation of the risk of congenital toxoplasmosis. II. Further data on the immune response during pregnancy].

Mihai M, Marinov R, Baciu G, Rener L, Vînătoru E, Blum L, Chirculescu O, Tîrziman I, Pricop M.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1978 Jul-Sep;23(3):147-52. Romanian.

PMID:
694330
17.

[Characteristics of the maintenance phase of malaria eradication in our country and its relation to the risk of renewed natural transmission].

Marinov R, Dranga A, Teodorescu C, Mihai M, Stratulat C, Bornuz M.

Rev Med Chir Soc Med Nat Iasi. 1977 Jul-Sep;81(3):417-20. Romanian. No abstract available.

PMID:
22908
18.

[Current aspects of the malaria problem].

Marinov R.

Rev Med Chir Soc Med Nat Iasi. 1977 Apr-Jun;81(2):181-5. Romanian. No abstract available.

PMID:
905672
19.

[Dynamics of the immune response in a familial focus of toxoplasmosis].

Dranga A, Marinov R, Mihai M, Teodorescu C.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1976 Oct-Dec;21(4):219-25. Romanian.

PMID:
138925
20.

[Contribution to the study of infestations with Ascaris lumbricoides in rural environments under the influence of mass helminthiasis control with piperazine adipate (Nematocton)].

Ungureanu E, Boldescu I, Marinov R, Petrea D, Stratulat C, Marderos C.

Rev Med Chir Soc Med Nat Iasi. 1969 Jan-Mar;73(1):97-102. Romanian. No abstract available.

PMID:
5799875

Supplemental Content

Loading ...
Support Center